Corneal Transplantation Clinical Trial
Official title:
Suppression of Graft Rejection Using Mixed Component Cornea in the High-risk Keratoplasty,A Randomized Controlled Trial.
Because of the immunologically privileged nature of the cornea, the graft rejection rate is less than 10% for low-risk keratoplasty. But when the cornea performed 2 or more quadrants of corneal neovascularization after ocular trauma or infection, the graft rejection rate is more than 65%, it is called high-risk keratoplasty. This study will observe the graft survival of high-risk corneal transplantation using mixed component cornea from different donors.
Ocular trauma or infection lead to corneal limbal stem cell deficiency and central corneal opacification which could only be treated by central penetrating keratoplasty and limbal transplantation, but the rejection rate is very high. In clinical, we found that limbal transplantation combined with central penetrating keratoplasty from different donors can keep the graft transparent for a long time, this result also be found in organ transplantation, multiple donor organ transplantation could reduce rejection risk in liver and kidney transplantation. Therefore, it is speculated that there are different MHC antigens from different donors, which cause different reactions after transplantation. Because there are a large number of Langerhans cells, abundant blood vessels and lymphatic in the limbal, so the rejection occurs early and severely. Continuous and intense limbal rejection leads to the depletion of recipient T cells, lead to the immune tolerance of another donor's central corneal tissue. In this project, central penetrating keratoplasty and limbal transplantation from different donors will be carried out and the graft survival of high-risk corneal transplantation will be observed in clinical, to find a new method for high-risk corneal transplant patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01206127 -
DSAEK- Postoperative Positioning and Transplant Dislocation
|
N/A | |
Terminated |
NCT00764582 -
Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery
|
Phase 4 | |
Recruiting |
NCT05870566 -
Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]
|
N/A | |
Recruiting |
NCT02084745 -
Timing of Glaucoma Drainage Device With Boston Keratoprosthesis
|
N/A | |
Unknown status |
NCT00834782 -
Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty
|
Phase 4 | |
Withdrawn |
NCT00345020 -
Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
|
||
Completed |
NCT00000137 -
Collaborative Corneal Transplantation Studies (CCTS)
|
Phase 3 | |
Recruiting |
NCT04339907 -
Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)
|
N/A | |
Active, not recruiting |
NCT00874835 -
Corneal Endothelium Delivery Instrument
|
Phase 2 | |
Completed |
NCT00570648 -
A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization
|
N/A | |
Enrolling by invitation |
NCT03461978 -
Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures
|
N/A | |
Not yet recruiting |
NCT05210478 -
Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea
|
||
Completed |
NCT01694914 -
Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium
|
Phase 3 | |
Completed |
NCT03381794 -
The German Keratoplasty Registry of the German Ophthalmological Society (DOG)
|
N/A | |
Recruiting |
NCT03105466 -
Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea
|
N/A | |
Completed |
NCT00409656 -
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients
|
Phase 2 | |
Recruiting |
NCT01018888 -
Safety and Efficacy Study of Artificial Cornea
|
Phase 4 | |
Recruiting |
NCT04337944 -
Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)
|
N/A | |
Completed |
NCT01547975 -
Retrospective Analysis of Surgical Outcomes After Corneal Transplantation
|
N/A | |
Terminated |
NCT00447642 -
Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
|
Phase 3 |